S Krauß

1.4k total citations
45 papers, 1.1k citations indexed

About

S Krauß is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, S Krauß has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in S Krauß's work include Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (17 papers) and Cancer Treatment and Pharmacology (7 papers). S Krauß is often cited by papers focused on Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (17 papers) and Cancer Treatment and Pharmacology (7 papers). S Krauß collaborates with scholars based in United States, Germany and Denmark. S Krauß's co-authors include Everett E. Vokes, G Omura, Lawrence H. Einhorn, F. Anthony Greco, Rafat Ansari, A Bartolucci, Charles L. Vogel, R V Smalley, John T. Carpenter and R. K. Oldham and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

S Krauß

44 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Krauß United States 17 678 423 360 233 192 45 1.1k
M. Wolf Germany 20 801 1.2× 342 0.8× 348 1.0× 436 1.9× 62 0.3× 72 1.3k
Henrik Roed Denmark 22 755 1.1× 525 1.2× 233 0.6× 309 1.3× 120 0.6× 56 1.8k
M Hansen Denmark 20 1.1k 1.6× 641 1.5× 513 1.4× 349 1.5× 55 0.3× 40 1.5k
Claudio Dazzi Italy 17 556 0.8× 494 1.2× 179 0.5× 220 0.9× 60 0.3× 57 982
Sandra J. Ginsberg United States 18 531 0.8× 316 0.7× 244 0.7× 115 0.5× 84 0.4× 38 931
Yeu‐Tsu N. Lee United States 16 614 0.9× 341 0.8× 128 0.4× 156 0.7× 66 0.3× 56 1.1k
Paolo De Giuli Italy 15 454 0.7× 384 0.9× 115 0.3× 331 1.4× 72 0.4× 19 1.2k
Charles K. Tashima United States 19 572 0.8× 385 0.9× 117 0.3× 98 0.4× 132 0.7× 54 1.1k
S.M. O'Reilly United Kingdom 14 641 0.9× 294 0.7× 75 0.2× 225 1.0× 293 1.5× 26 1.2k
A. Y. Chang United States 17 724 1.1× 494 1.2× 106 0.3× 230 1.0× 59 0.3× 40 1.3k

Countries citing papers authored by S Krauß

Since Specialization
Citations

This map shows the geographic impact of S Krauß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Krauß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Krauß more than expected).

Fields of papers citing papers by S Krauß

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Krauß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Krauß. The network helps show where S Krauß may publish in the future.

Co-authorship network of co-authors of S Krauß

This figure shows the co-authorship network connecting the top 25 collaborators of S Krauß. A scholar is included among the top collaborators of S Krauß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Krauß. S Krauß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choong, Nicholas W., Ann M. Mauer, Mark K. Ferguson, et al.. (2010). Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Medical Oncology. 28(S1). 152–161. 11 indexed citations
2.
Choong, Nicholas W., Everett E. Vokes, Daniel J. Haraf, et al.. (2008). Phase I Study of Induction Chemotherapy and Concomitant Chemoradiotherapy with Irinotecan, Carboplatin, and Paclitaxel for Stage III Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 3(1). 59–67. 5 indexed citations
3.
Mauer, Ann M., Eric H. Kraut, S Krauß, et al.. (2005). Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus. Annals of Oncology. 16(8). 1320–1325. 48 indexed citations
4.
Mauer, Ann M., Rafat Ansari, P C Hoffman, et al.. (2003). Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer. Annals of Oncology. 14(5). 722–728. 3 indexed citations
5.
Hoffman, Philip C., Ezra E.W. Cohen, Gregory A. Masters, et al.. (2002). Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study. Lung Cancer. 38(1). 65–71. 16 indexed citations
6.
Vokes, Everett E., Chaiyut Charoentum, Charles M. Rudin, et al.. (2002). Phase I Study of Dose-Dense Alternating Doublets in Advanced Non—Small-Cell Lung Cancer. Clinical Lung Cancer. 3(4). 265–270. 1 indexed citations
7.
8.
George, Christopher, Ann M. Mauer, S Krauß, et al.. (2001). A Phase I Trial of the Oral Platinum Analogue JM216 with Concomitant Radiotherapy in Advanced Malignancies of the Chest. Investigational New Drugs. 19(4). 303–310. 17 indexed citations
9.
Vokes, Everett E., Charles M. Rudin, Ann M. Mauer, et al.. (2001). A Phase II Trial of 9-Aminocaptothecin (9-AC) as a 120-h Infusion in Patients with Non-Small Cell Lung Cancer. Investigational New Drugs. 19(4). 329–333. 18 indexed citations
10.
Vokes, Everett E., Ann M. Mauer, Charles M. Rudin, et al.. (2000). A Phase I Study of STEALTH® Cisplatin (SPI-77) and Vinorelbine in Patients with Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 2(2). 128–132. 12 indexed citations
11.
Masters, Gregory A., Daniel J. Haraf, P C Hoffman, et al.. (1998). Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies.. Journal of Clinical Oncology. 16(6). 2157–2163. 41 indexed citations
12.
Masters, Gregory A., Ann M. Mauer, Brian L. Samuels, et al.. (1998). A phase I–II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer. Annals of Oncology. 9(6). 677–680. 6 indexed citations
13.
Kowalczuk, Andrew, R. Loch Macdonald, George J. Dohrmann, et al.. (1997). Quantitative Imaging Study of Extent of Surgical Resection and Prognosis of Malignant Astrocytomas. Neurosurgery. 41(5). 1028–1038. 181 indexed citations
14.
Vokes, Everett E., et al.. (1997). Ifosfamide-based chemotherapy for non-small cell lung cancer: Phase I/II studies at the University of Chicago. Lung Cancer. 16(2-3). 276–276. 3 indexed citations
15.
Hoffman, P C, Gregory A. Masters, S Krauß, et al.. (1996). Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: A phase I study. Annals of Oncology. 7(3). 314–316. 15 indexed citations
16.
Hoffman, P C, Gregory A. Masters, S Krauß, et al.. (1996). Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.. PubMed. 23(3 Suppl 6). 11–5. 3 indexed citations
17.
Johnson, Douglas H., Lawrence H. Einhorn, Robert Birch, et al.. (1987). A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.. Journal of Clinical Oncology. 5(11). 1731–1738. 99 indexed citations
18.
Krauß, S, Lawrence E. Broder, & Robert Birch. (1986). Guanazole in the treatment of advanced bronchogenic carcinoma: a pilot study of the Southeastern Cancer Study Group.. PubMed. 70(7). 913–4. 3 indexed citations
19.
Tichler, Thomas, et al.. (1979). "CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma.. PubMed. 2(4). 321–6. 6 indexed citations
20.
Krauß, S. (1971). Post-hypoglycaemic encephalopathy.. BMJ. 2(5761). 591.1–591. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Wolf Breakdown of academic impact, for papers by Henrik Roed Breakdown of academic impact, for papers by M Hansen Breakdown of academic impact, for papers by Claudio Dazzi Breakdown of academic impact, for papers by Sandra J. Ginsberg Breakdown of academic impact, for papers by Yeu‐Tsu N. Lee Breakdown of academic impact, for papers by Paolo De Giuli Breakdown of academic impact, for papers by Charles K. Tashima Breakdown of academic impact, for papers by S.M. O'Reilly Breakdown of academic impact, for papers by A. Y. Chang
Rankless by CCL
2026